The construction and evaluation of SIV/HIV chimeras that express the envelope of European HIV type 1 isolates.

@article{Ranjbar1997TheCA,
  title={The construction and evaluation of SIV/HIV chimeras that express the envelope of European HIV type 1 isolates.},
  author={S Amini Ranjbar and S L Jones and E. J. Stott and Neil M. Almond},
  journal={AIDS research and human retroviruses},
  year={1997},
  volume={13 9},
  pages={
          797-800
        }
}
The molecular construction of SIV/HIV-1 chimeric viruses (or SHIVs), provides a means of infecting macaques with immunodeficiency viruses that express the envelope protein of HIV-1. However, to date, most SHIVs produced express the envelope of isolates of HIV-1 that have been passaged repeatedly in T cell lines. We have taken SHIV-4 and replaced an NheI-AvrII fragment that encompasses the gp120 region and the extracellular portion of gp41 with the equivalent region of two European isolates of… Expand
Evaluation of a candidate human immunodeficiency virus type 1 (HIV-1) vaccine in macaques: effect of vaccination with HIV-1 gp120 on subsequent challenge with heterologous simian immunodeficiency virus-HIV-1 chimeric virus.
TLDR
Despite strong immune responses to the vaccine there was no evidence that it protected against challenge with this chimeric virus, and the antigenic divergence between vaccine and challenge virus or the increased virulence of the challenge virus may be responsible for the inability of this vaccine to protect against infection by SHIV(SF33). Expand
Evidence for Viral Virulence as a Predominant Factor Limiting Human Immunodeficiency Virus Vaccine Efficacy
TLDR
A series of heterologous chimeric simian/human immunodeficiency virus (SHIV) challenge experiments in HIV-1 subunit-vaccinated rhesus macaques revealed different levels of protective immunity, suggesting the importance of developing vaccine strategies capable of protecting from particularly virulent variants of HIV- 1. Expand
A clinically relevant HIV‐1 subunit vaccine protects rhesus macaques from in vivo passaged simian–human immunodeficiency virus infection
TLDR
In a relatively large number of primates, vaccine efficacy was demonstrated with a clinically relevant HIV-1 vaccine, revealing that it is possible to induce sterilizing immunity sufficient to protect from infection with SHIV which was passaged multiple times in vivo. Expand
Coreceptor switch in infection of nonhuman primates.
TLDR
The underlying basis for virus coreceptor switch late in infection remains an enigma, but will be important to understand given that the appearance of X4 virus in HIV-1 infected patients inevitably heralds an unfavorable clinical outcome. Expand
Towards an HIV-1 vaccine: lessons from studies in macaque models.
TLDR
Evaluation of new lentivirus vaccine strategies may largely benefit from the use of the newly developed chimeric simian-human immunodeficiency viruses, allowing the testing of HIV-1 antigen based vaccines in macaques. Expand
Review Article HIV-Derived Lentiviral Vectors: Current Progress toward Gene Therapy and DNA Vaccination
TLDR
This review will summarize new developments on HIV-1 vectors, while focusing on alternate strategies toward developing HIV-2-based vectors. Expand
Protection of Macaques against Pathogenic Simian/Human Immunodeficiency Virus 89.6PD by Passive Transfer of Neutralizing Antibodies
TLDR
A general correlation between in vitro neutralization and protection is indicated and it is suggested that a vaccine that elicits neutralizing antibody should have a protective effect against HIV-1 infection or disease. Expand
Chapter 10 – Simian Retroviruses
TLDR
In the natural African simian hosts, SIV does not cause any disease, but experimental infection of captive macaques with certain SIV strains produces a progressive and fatal immunodeficiency syndrome similar to AIDS in humans, making this primate lentivirus model very useful for research into AIDS pathogenesis, vaccines, and antiviral therapy. Expand
Heterologous protection elicited by candidate monomeric recombinant HIV-1 gp120 vaccine in the absence of cross neutralising antibodies in a macaque model
TLDR
Protection was observed against heterologous virus challenge with SHIVsbg, but not SHIVSF33, and did not correlate with serological responses generated by vaccination, but might be associated with T cell proliferative responses against an epitope in the second constant region of HIV-1 gp120. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 13 REFERENCES
Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells
TLDR
Western immunoblotting analysis of the replicating chimera in PBMC confirmed the hybrid nature of the virus and suggested that the sequence important for macaque cell tropism lies within the LTR, gag, pol, and/or vif sequences of the SIVMAC genome. Expand
Human immunodeficiency virus type 1 cellular host range, replication, and cytopathicity are linked to the envelope region of the viral genome
TLDR
Results obtained by using recombinant viruses generated in this manner indicate that the ability of HIV to replicate in specific cell types and cytopathicity segregate with the env region of the viral genome. Expand
Molecular cloning and characterization of a German HIV-1 isolate.
TLDR
Comparative studies of the nucleic acid sequence revealed that this isolate, designated HAN2, is highly divergent from the North American and African subtypes of HIV-1 and may represent a European subtype of AIDS-related complex. Expand
An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeys
TLDR
With the demonstration that a chimeric SHIV can replicate to high levels during primary infection in rhesus monkeys, this model can now be used to define genetic determinants of HIV-1 pathogenicity. Expand
Identification of viral determinants of macrophage tropism for simian immunodeficiency virus SIVmac
TLDR
It is concluded that gp130 env and one or more genetic elements are essential for a complete replication cycle of SIVmac in rhesus macaque macrophages but not sufficient for acomplete viral replication cycle in this cell type. Expand
Persistent infection of macaques with simian-human immunodeficiency viruses
TLDR
The consistency with which SHIV infection of cynomolgus monkeys is initiated and the similarities in the neutralizing antibody response to SHIV and HIV-1 support the utility of this model system for the study of HIV- 1 prophylaxis. Expand
The development of PCR based assays for the detection and differentiation of simian immunodeficiency virus in vivo.
TLDR
These sensitive and specific assays complement virological detection of SIV and enable superinfection studies to be evaluated; a prerequisite for the testing of live attenuated immunodeficiency virus vaccines. Expand
Complex determinants of macrophage tropism in env of simian immunodeficiency virus
TLDR
The emergence of macrophagetropic variants in vivo was associated with specific pathologic manifestations in which the macrophage is the major infected cell type, and the presence ofmacrophage-tropic virus variant in vivo can influence the disease course and disease manifestations. Expand
Phenotype-associated env gene variation among eight related human immunodeficiency virus type 1 clones: evidence for in vivo recombination and determinants of cytotropism outside the V3 domain
TLDR
The nucleotide sequences of the env genes of eight phenotypically heterogeneous human immunodeficiency virus type 1 (HIV-1) clones recovered from a single individual within a 3-week period were compared and demonstrated that the HIV-1 env gene determined the capacity to induce syncytia and tropism for T-cell lines. Expand
CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5
TLDR
CD4 binding, although not absolutely necessary for the gp120–CCR-5 interaction, greatly increases its efficiency, and interference with HIV-1 binding to one or both of its receptors (CD4 and CCR-5) may be an important mechanism of virus neutralization. Expand
...
1
2
...